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ABSTRACT 
 
Aims: The platelet-derived growth factor β-receptor (PDGFRB) is critically involved in 
embryonic development and has a role in many diseases. In cells, signaling through PDGFRB 
affects growth, migration and death. The role of PDGFRB in these crucial processes 
necessitates strict regulation and therefore it is regulated in many ways, including 
transcription, dephosphorylation, internalization, and degradation. Of these, transcriptional 
regulation is the least studied. Previously, PDGFRB transcription has been shown to be under 
the control of the transcription factors nuclear factor y (NF-Y), specificity protein 1 (Sp1) and 
the p53 family member p73. In the present thesis we investigated the role of p53 family 
members and their mechanisms for transcriptional regulation of PDGFRB. 
 
Results: In search for the mechanism behind p73α-mediated repression of the PDGFRB, we 
found that p73α competed with histone acetyltransferases for binding to NF-Y. The 
recruitment of p73α and ∆Np73 to the PDGFRB promoter corresponded with PDGFRB 
expression. In repression of the PDGFRB promoter, p73 was recruited with the co-repressor 
HDAC1. Binding of ∆Np73 and the co-activator p300, on the other hand, corresponded to 
PDGFRB promoter induction. 
Overexpression of the p53 interacting viral large T antigen (LT) in NIH3T3 fibroblasts 
resulted in repressed PDGFRB promoter activity and decreased expression of PDGFRB 
protein and mRNA. The same type of overexpression in c-Myc–/– HO15.19 fibroblasts, Rb–/–
NIH3T3, and pRb- and p53-lacking osteosarcoma, Saos2, did not repress PDGFRB promoter 
activity, showing the importance of these molecules for LT-mediated repression of PDGFRB.  
In order to identify the role of p53, we overexpressed p53 in mouse embryonic fibroblasts 
(MEF), p53–/– MEF, and Saos2, which induced repression of PDGFRB promoter activity and 
decreased mRNA and protein expression. Endogenous p53 activated by mitomycin treatment 
also downregulated PDGFRB expression. Experiments showed that p53 could bind the 
PDGFRB promoter region surrounding the CCAAT-motif. Upon p53 induction, when 
PDGFRB expression was repressed, p53 and HDAC1 bound the PDGFRB promoter and the 
co-activator p300 was dismissed.  
The role of ∆Np73 in PDGFRB expression was investigated using the neuroblastoma cell 
line IMR-32 which had dysregulated PDGFRB expression and SH-SY5Y which had regulated 
expression. Silencing of ∆Np73 repressed PDGFRB promoter activity and protein expression 
in IMR-32 but not in SH-SY5Y and ∆Np73 was constitutively bound to the PDGFRB 
promoter only in IMR-32. Treatment with the anticancer drug cisplatin decreased PDGFRB 
protein, mRNA and promoter activity in both cell lines. In IMR-32, cisplatin was found to 
dismiss ∆Np73 and p300 from the PDGFRB promoter and recruit HDAC4. 
 
Conclusions: Results presented in this thesis suggest a role for p53 family members in 
downregulation of PDGFRB expression upon growth stimulation or in response to DNA 
damage. In addition, we demonstrated that ∆Np73 have a role in dysregulated PDGFRB 
expression. Also, we propose a potential for tyrosine kinase inhibitors in the treatment of 
neuroblastoma with high ∆Np73 and PDGFR expression. 
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